Cargando…

213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections

BACKGROUND: Persons who inject drugs (PWID) with opioid use disorder (OUD) are at increased risk of invasive bacterial and fungal infections, which warrant prolonged, inpatient parenteral antimicrobial therapy. Such admissions are complicated by opioid cravings and withdrawal. Comparisons of medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Marks, Laura, Schwarz, Evan, Liss, David, Satish, Munigala, Warren, David K, Stephen, Liang, Durkin, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810735/
http://dx.doi.org/10.1093/ofid/ofz360.288
_version_ 1783462317168525312
author Marks, Laura
Schwarz, Evan
Liss, David
Satish, Munigala
Warren, David K
Stephen, Liang
Durkin, Michael
author_facet Marks, Laura
Schwarz, Evan
Liss, David
Satish, Munigala
Warren, David K
Stephen, Liang
Durkin, Michael
author_sort Marks, Laura
collection PubMed
description BACKGROUND: Persons who inject drugs (PWID) with opioid use disorder (OUD) are at increased risk of invasive bacterial and fungal infections, which warrant prolonged, inpatient parenteral antimicrobial therapy. Such admissions are complicated by opioid cravings and withdrawal. Comparisons of medications for OUD during prolonged admissions for these patients have not been previously reported. The aim of this study was to evaluate the impact of different OUD treatment strategies in this population, and their impact on ED and hospital readmissions. METHODS: We retrospectively analyzed consecutive admissions for invasive bacterial or fungal infections in PWID, admitted between January 2016 and January 2019 at Barnes-Jewish Hospital. Patients in our cohort were required to receive an infectious diseases consult, and an anticipated antibiotic treatment duration of >2 weeks. We collected data on demographics, comorbidities, length of stay, microbiologic data, medications prescribed for OUD, mortality, and readmission rates. We compared 90-day readmission rates by OUD treatment strategies using Kaplan–Meier curves. RESULTS: In our cohort of 237 patients, treatment of OUD was buprenorphine (17.5%), methadone (25.3%), or none (56.2%). Among patients receiving OUD treatment, 30% had methadone tapers and/or methadone discontinued upon discharge. Patient demographics were similar for each OUD treatment strategy. Infection with HIV (2.8%), and hepatitis B (3%), and hepatitis C (67%) were similar between groups. Continuation of medications for OUD was associated with increased completion of parenteral antibiotics (odds ratio 2.11; 95% confidence interval 1.70–2.63). When comparing medications for OUD strategies, methadone had the lowest readmission rates, followed by buprenorphine, and no treatment (P = 0.0013) (figure). Discontinuation of methadone during the admission or upon discharge was associated with the highest readmission rates. CONCLUSION: Continuation of OUD treatment without tapering, was associated with improved completion of parenteral antimicrobials in PWID with invasive bacterial or fungal infections lower readmission rates. Tapering OUD treatment during admission was associated with higher readmission rates. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810735
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68107352019-10-28 213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections Marks, Laura Schwarz, Evan Liss, David Satish, Munigala Warren, David K Stephen, Liang Durkin, Michael Open Forum Infect Dis Abstracts BACKGROUND: Persons who inject drugs (PWID) with opioid use disorder (OUD) are at increased risk of invasive bacterial and fungal infections, which warrant prolonged, inpatient parenteral antimicrobial therapy. Such admissions are complicated by opioid cravings and withdrawal. Comparisons of medications for OUD during prolonged admissions for these patients have not been previously reported. The aim of this study was to evaluate the impact of different OUD treatment strategies in this population, and their impact on ED and hospital readmissions. METHODS: We retrospectively analyzed consecutive admissions for invasive bacterial or fungal infections in PWID, admitted between January 2016 and January 2019 at Barnes-Jewish Hospital. Patients in our cohort were required to receive an infectious diseases consult, and an anticipated antibiotic treatment duration of >2 weeks. We collected data on demographics, comorbidities, length of stay, microbiologic data, medications prescribed for OUD, mortality, and readmission rates. We compared 90-day readmission rates by OUD treatment strategies using Kaplan–Meier curves. RESULTS: In our cohort of 237 patients, treatment of OUD was buprenorphine (17.5%), methadone (25.3%), or none (56.2%). Among patients receiving OUD treatment, 30% had methadone tapers and/or methadone discontinued upon discharge. Patient demographics were similar for each OUD treatment strategy. Infection with HIV (2.8%), and hepatitis B (3%), and hepatitis C (67%) were similar between groups. Continuation of medications for OUD was associated with increased completion of parenteral antibiotics (odds ratio 2.11; 95% confidence interval 1.70–2.63). When comparing medications for OUD strategies, methadone had the lowest readmission rates, followed by buprenorphine, and no treatment (P = 0.0013) (figure). Discontinuation of methadone during the admission or upon discharge was associated with the highest readmission rates. CONCLUSION: Continuation of OUD treatment without tapering, was associated with improved completion of parenteral antimicrobials in PWID with invasive bacterial or fungal infections lower readmission rates. Tapering OUD treatment during admission was associated with higher readmission rates. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810735/ http://dx.doi.org/10.1093/ofid/ofz360.288 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Marks, Laura
Schwarz, Evan
Liss, David
Satish, Munigala
Warren, David K
Stephen, Liang
Durkin, Michael
213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections
title 213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections
title_full 213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections
title_fullStr 213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections
title_full_unstemmed 213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections
title_short 213. A Comparison of Medication Assisted Therapy Treatment Strategies for Opioid Use Disorder in Persons who Inject Drugs and are Hospitalized with Serious Infections
title_sort 213. a comparison of medication assisted therapy treatment strategies for opioid use disorder in persons who inject drugs and are hospitalized with serious infections
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810735/
http://dx.doi.org/10.1093/ofid/ofz360.288
work_keys_str_mv AT markslaura 213acomparisonofmedicationassistedtherapytreatmentstrategiesforopioidusedisorderinpersonswhoinjectdrugsandarehospitalizedwithseriousinfections
AT schwarzevan 213acomparisonofmedicationassistedtherapytreatmentstrategiesforopioidusedisorderinpersonswhoinjectdrugsandarehospitalizedwithseriousinfections
AT lissdavid 213acomparisonofmedicationassistedtherapytreatmentstrategiesforopioidusedisorderinpersonswhoinjectdrugsandarehospitalizedwithseriousinfections
AT satishmunigala 213acomparisonofmedicationassistedtherapytreatmentstrategiesforopioidusedisorderinpersonswhoinjectdrugsandarehospitalizedwithseriousinfections
AT warrendavidk 213acomparisonofmedicationassistedtherapytreatmentstrategiesforopioidusedisorderinpersonswhoinjectdrugsandarehospitalizedwithseriousinfections
AT stephenliang 213acomparisonofmedicationassistedtherapytreatmentstrategiesforopioidusedisorderinpersonswhoinjectdrugsandarehospitalizedwithseriousinfections
AT durkinmichael 213acomparisonofmedicationassistedtherapytreatmentstrategiesforopioidusedisorderinpersonswhoinjectdrugsandarehospitalizedwithseriousinfections